Evidence map›Paper›PMID 11390413›Full record

ReviewThe Journal of clinical investigation2001

Arachidonic acid as a bioactive molecule.

A R Brash

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Single-cell and spatial transcriptomics reveal an arachidonic acid-related cellular atlas in lung adenocarcinoma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Unraveling enantioselective metabolism: Human cytochrome P450s in arachidonic acid biotransformation.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Roles of Lipoxygenases in Cardiovascular Diseases.Journal of cardiovascular translational research · 2025
    Review
  20. Can Bisphenols Alter the Inflammation Process?Life (Basel, Switzerland) · 2025
    Review

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A R BrashDivision of Clinical Pharmacology, Vanderbilt University Medical Center, 23rd Avenue at Pierce, Nashville, Tennessee 37232-6602, USA. alan.brash@mcmail.vanderbilt.edu

Funding

Novel Oxygenations of Arachidonic Acid (Supplement)R01GM053638 · NIGMS · VANDERBILT UNIVERSITY · PI BRASH, ALAN R. · 1997 to 2006
$1.6M
PATHOPHYSIOLOGICAL ROLE OF 12-R-LIPOXYGENASER01AR045943 · NIAMS · VANDERBILT UNIVERSITY · PI BRASH, ALAN R. · 1999 to 2002
$808k
NIAMS NIH HHS AR-45943NIAMS NIH HHS R01 AR045943NIGMS NIH HHS GM-53638NIGMS NIH HHS R01 GM053638
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoptosisArachidonic AcidBiological TransportCell MembraneHumansMembrane ProteinsMolecular StructureOxygenOxygenasesSolubilityArachidonic AcidMembrane ProteinsOxygenOxygenases

Identifiers

PMID11390413
PMCPMC209328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.